ao link

You are viewing 1 of your 3 articles before login/registration is required

References

  1. M Brujic, H Ilyas, “The ultimate guide to Upneeq for eyelid ptosis.” Available at eyesoneyecare.com/resources/the-ultimate-guide-to-upneeq-for-eyelid-ptosis/
  2. B Esmaeli-Gutstein et al., “Distribution of adrenergic receptor subtypes in the retractor muscles of the upper eyelid,” Ophthalmic Plast Reconstr Surg., 15, 92-99 (1999).
  3. B Haenisch et al., “Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline,” Fundam Clin Pharmacol., 24, 729-739 (2010).
  4. CB Slonim et al., “Association of oxymetazoline hydrochloride, 0.1%, solution administration with visual field in acquired ptosis: a pooled analysis of 2 randomized clinical trials,” JAMA Ophthalmol.,138, 1168-1175 (2020).
  5. DL Wirta et al., “Safety of once-daily oxymetazoline HCl ophthalmic solution, 0.1% in patients with acquired blepharoptosis: results from four randomized, double-masked clinical trials,” Clin Ophthalmol., 15, 4035-4048 (2021).

Selina R. McGee

The New Optometrist Newsletter

Features


Comment: The New UK NHS and Independent Sector Partnership

Comment: The New UK NHS and Independent Sector Partnership


Eye On History: Oswald von Wolkenstein

Eye On History: Oswald von Wolkenstein


Eagle-Eyed: Treating an Injured Apex Predator

Eagle-Eyed: Treating an Injured Apex Predator


Eye on the Horizon: Smart Contact Lenses

Eye on the Horizon: Smart Contact Lenses

Sign up to The New Optometrist Updates

Sign up here to receive our latest interviews, features, reports and more.

Features

Comment: The New UK NHS and Independent Sector Partnership

Comment: The New UK NHS and Independent Sector Partnership

Eye On History: Oswald von Wolkenstein

Eye On History: Oswald von Wolkenstein

Eagle-Eyed: Treating an Injured Apex Predator

Eagle-Eyed: Treating an Injured Apex Predator

Eye on the Horizon: Smart Contact Lenses

Eye on the Horizon: Smart Contact Lenses

Sign up to The New Optometrist Updates

© 2023 Texere Publishing Inc. All rights reserved. Reproduction in the whole or in parts is prohibited. 
Follow us on Twitter
Follow us on Facebook
Follow us on LinkedIn
Texere Publishing